About Adaptyx Biosciences
Adaptyx Biosciences is a company based in Menlo Park (United States) founded in 2022 by Alex Yoshikawa. Adaptyx Biosciences has raised $14 million across 2 funding rounds from investors including University Lab Partners, Interlagos and Overwater Ventures. The company has 11 employees as of December 31, 2023. Adaptyx Biosciences operates in a competitive market with competitors including Level Zero Health, DIA Sensor, R&D Intercell and POMHealth, among others.
- Headquarter Menlo Park, United States
- Employees 11 as on 31 Dec, 2023
- Founders Alex Yoshikawa
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Adaptyx Biosciences Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14 M (USD)
in 2 rounds
-
Latest Funding Round
$14 M (USD), Seed
Oct 20, 2025
-
Investors
University Lab Partners
& 9 more
-
Employee Count
11
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Adaptyx Biosciences
Adaptyx Biosciences has successfully raised a total of $14M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $14 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Adaptyx Biosciences
Adaptyx Biosciences has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include University Lab Partners, Interlagos and Overwater Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Interlagos is engaged in technology investment activities.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are provided to innovative founders.
|
Locked | Locked | Locked | |
|
No specific activity is described for this company.
|
Locked | Locked | Locked |
Investor details for Adaptyx Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adaptyx Biosciences
Investment portfolio details for Adaptyx Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Adaptyx Biosciences
Detailed financials for Adaptyx Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adaptyx Biosciences Comparisons
Peer comparison for Adaptyx Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adaptyx Biosciences
Adaptyx Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Level Zero Health, DIA Sensor, R&D Intercell and POMHealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of biosensor technology for continuous hormone monitoring
|
|
| Locked | Locked | Locked |
Developer of electrochemical sensors to measure a panel of biomarkers
|
|
| Locked | Locked | Locked |
Wearable devices for molecular biomarker monitoring are developed.
|
|
| Locked | Locked | Locked |
Offers connected, holistic healthcare services to empower patients and clinicians globally.
|
Detailed competitors of Adaptyx Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adaptyx Biosciences
Complete news archive for Adaptyx Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adaptyx Biosciences
Adaptyx Biosciences was founded in 2022 and raised its 1st funding round 3 years after it was founded.
Adaptyx Biosciences is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Adaptyx Biosciences is a funded company, having raised a total of $14M across 2 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Adaptyx Biosciences is 11.
Platform offering microneedle sensor patch. It provides biosensors and diagnostic solutions that leverage aptamer based molecular switching technology. The devices uses technology to monitor blood and detect multiple biomarkers simultaneously, with potential applications in various healthcare settings.
Adaptyx Biosciences's top competitors include Level Zero Health, DIA Sensor and R&D Intercell.
Adaptyx Biosciences has 10 investors. Key investors include University Lab Partners, Interlagos, Overwater Ventures, Starbloom, and Leland Stanford Junior University.